2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective
{{output}}
Background: The demographic shift of pulmonary arterial hypertension (PAH) patients, the expanding therapeutic armamentarium with new emerging drugs and the heterogenous experience in handling more complex therapies are making th... ...
